STOCK TITAN

Maverick Capital (IVVD) discloses 6.7% Invivyd stake in Schedule 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Maverick Capital and related entities report a passive stake in Invivyd, Inc. (IVVD). As of December 31, 2025, Maverick Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III collectively report beneficial ownership of 18,970,913 shares of Invivyd common stock, representing 6.7% of the outstanding shares, based on 281,987,033 shares reported by the company. The shares are held in client accounts of Maverick-managed funds, and the filers certify that the holdings were not acquired to change or influence control of Invivyd.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Maverick Capital, Ltd.
Signature:/s/ Trevor Wiessmann*
Name/Title:By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Date:02/13/2026
Maverick Capital Management, LLC
Signature:/s/ Trevor Wiessmann*
Name/Title:Lee S. Ainslie III, Manager
Date:02/13/2026
Lee S. Ainslie III
Signature:/s/ Trevor Wiessmann*
Name/Title:Lee S. Ainslie III
Date:02/13/2026

Comments accompanying signature: *Under Power of Attorney, dated March 15, 2018

FAQ

How many Invivyd (IVVD) shares does Maverick Capital report owning?

Maverick Capital and related entities report beneficial ownership of 18,970,913 Invivyd common shares. These shares are held in client accounts of several Maverick-managed funds, and the position is reported jointly by Maverick Capital, Maverick Capital Management, and Lee S. Ainslie III.

What percentage of Invivyd (IVVD) does Maverick Capital’s 13G/A filing represent?

The filing shows Maverick Capital and affiliates beneficially own 6.7% of Invivyd’s common stock. This percentage is calculated using 281,987,033 outstanding shares as of December 31, 2025, as reported by Invivyd in an accompanying company disclosure.

Is Maverick Capital’s Invivyd (IVVD) stake a control or passive investment?

The filing characterizes Maverick Capital’s Invivyd stake as passive. The signatories certify the securities were not acquired or held for the purpose of changing or influencing control of Invivyd, but instead are held in client accounts consistent with a non-control investment intent.

Who are the reporting persons in the Invivyd (IVVD) Schedule 13G/A?

The reporting persons are Maverick Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III. Maverick Capital is the investment adviser to multiple funds holding Invivyd shares, Maverick Capital Management is its general partner, and Ainslie is the manager of Maverick Capital Management.

How is Maverick Capital’s Invivyd (IVVD) ownership structured across its funds?

The filing notes Invivyd shares are held for clients of Maverick Capital, including funds such as Maverick Fund USA, Ltd., Maverick Fund II, Ltd., Maverick Long Enhanced Fund, Ltd., Maverick HP, L.P., and Maverick Long Fund, Ltd., each holding specific share amounts.

What reference share count does Maverick Capital use for its Invivyd (IVVD) ownership percentage?

Maverick Capital’s 6.7% ownership figure is based on 281,987,033 Invivyd shares outstanding as of December 31, 2025. This outstanding share count comes from Invivyd’s disclosure in Exhibit 99.1 to a Current Report on Form 8-K filed with the SEC.
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

431.44M
228.39M
19.2%
60.75%
2.52%
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
NEW HAVEN